LEXX
Price
$0.90
Change
-$0.09 (-9.18%)
Updated
Jul 28, 04:58 PM (EDT)
Capitalization
19.13M
Earnings call today
PDSB
Price
$1.17
Change
-$0.01 (-0.85%)
Updated
Jul 28, 04:59 PM (EDT)
Capitalization
53.94M
16 days until earnings call
Interact to see
Advertisement

LEXX vs PDSB

Header iconLEXX vs PDSB Comparison
Open Charts LEXX vs PDSBBanner chart's image
Lexaria Bioscience
Price$0.90
Change-$0.09 (-9.18%)
Volume$934
Capitalization19.13M
PDS Biotechnology
Price$1.17
Change-$0.01 (-0.85%)
Volume$700
Capitalization53.94M
LEXX vs PDSB Comparison Chart in %
Loading...
LEXX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PDSB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
LEXX vs. PDSB commentary
Jul 29, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LEXX is a Hold and PDSB is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 29, 2025
Stock price -- (LEXX: $0.98 vs. PDSB: $1.18)
Brand notoriety: LEXX and PDSB are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: LEXX: 142% vs. PDSB: 36%
Market capitalization -- LEXX: $19.13M vs. PDSB: $53.94M
LEXX [@Biotechnology] is valued at $19.13M. PDSB’s [@Biotechnology] market capitalization is $53.94M. The market cap for tickers in the [@Biotechnology] industry ranges from $313.33B to $0. The average market capitalization across the [@Biotechnology] industry is $2.56B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

LEXX’s FA Score shows that 0 FA rating(s) are green whilePDSB’s FA Score has 1 green FA rating(s).

  • LEXX’s FA Score: 0 green, 5 red.
  • PDSB’s FA Score: 1 green, 4 red.
According to our system of comparison, LEXX is a better buy in the long-term than PDSB.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

LEXX’s TA Score shows that 4 TA indicator(s) are bullish while PDSB’s TA Score has 5 bullish TA indicator(s).

  • LEXX’s TA Score: 4 bullish, 5 bearish.
  • PDSB’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, PDSB is a better buy in the short-term than LEXX.

Price Growth

LEXX (@Biotechnology) experienced а +3.44% price change this week, while PDSB (@Biotechnology) price change was +2.61% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +6.74%. For the same industry, the average monthly price growth was +20.88%, and the average quarterly price growth was +48.02%.

Reported Earning Dates

LEXX is expected to report earnings on Oct 29, 2025.

PDSB is expected to report earnings on Nov 12, 2025.

Industries' Descriptions

@Biotechnology (+6.74% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PDSB($53.9M) has a higher market cap than LEXX($19.1M). PDSB YTD gains are higher at: -27.607 vs. LEXX (-53.429). LEXX has higher annual earnings (EBITDA): -9.32M vs. PDSB (-33.08M). PDSB has more cash in the bank: 40M vs. LEXX (6.54M). LEXX has less debt than PDSB: LEXX (124K) vs PDSB (19M). LEXX has higher revenues than PDSB: LEXX (526K) vs PDSB (0).
LEXXPDSBLEXX / PDSB
Capitalization19.1M53.9M35%
EBITDA-9.32M-33.08M28%
Gain YTD-53.429-27.607194%
P/E RatioN/AN/A-
Revenue526K0-
Total Cash6.54M40M16%
Total Debt124K19M1%
FUNDAMENTALS RATINGS
LEXX vs PDSB: Fundamental Ratings
LEXX
PDSB
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
42
Fair valued
30
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9998
PRICE GROWTH RATING
1..100
6590
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
8550

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

PDSB's Valuation (30) in the Pharmaceuticals Major industry is in the same range as LEXX (42) in the null industry. This means that PDSB’s stock grew similarly to LEXX’s over the last 12 months.

PDSB's Profit vs Risk Rating (100) in the Pharmaceuticals Major industry is in the same range as LEXX (100) in the null industry. This means that PDSB’s stock grew similarly to LEXX’s over the last 12 months.

PDSB's SMR Rating (98) in the Pharmaceuticals Major industry is in the same range as LEXX (99) in the null industry. This means that PDSB’s stock grew similarly to LEXX’s over the last 12 months.

LEXX's Price Growth Rating (65) in the null industry is in the same range as PDSB (90) in the Pharmaceuticals Major industry. This means that LEXX’s stock grew similarly to PDSB’s over the last 12 months.

LEXX's P/E Growth Rating (100) in the null industry is in the same range as PDSB (100) in the Pharmaceuticals Major industry. This means that LEXX’s stock grew similarly to PDSB’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
LEXXPDSB
RSI
ODDS (%)
Bearish Trend 4 days ago
90%
Bullish Trend 4 days ago
80%
Stochastic
ODDS (%)
Bearish Trend 4 days ago
82%
Bullish Trend 4 days ago
87%
Momentum
ODDS (%)
Bullish Trend 4 days ago
88%
Bearish Trend 5 days ago
90%
MACD
ODDS (%)
Bullish Trend 4 days ago
90%
Bullish Trend 4 days ago
88%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
85%
Bullish Trend 4 days ago
84%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
87%
Bearish Trend 4 days ago
89%
Advances
ODDS (%)
Bullish Trend 6 days ago
86%
Bullish Trend 20 days ago
86%
Declines
ODDS (%)
Bearish Trend 4 days ago
84%
Bearish Trend 4 days ago
89%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
90%
Bullish Trend 4 days ago
90%
Aroon
ODDS (%)
Bearish Trend 4 days ago
80%
Bearish Trend 4 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
LEXX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PDSB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
HNNA12.890.23
+1.82%
Hennessy Advisors
DNTUF19.37N/A
N/A
Dentsu Group Inc.
CADLF5.50N/A
N/A
CADELER AS
SVII11.85N/A
N/A
Spring Valley Acquisition Corp
AVBH22.90-0.02
-0.09%
Avidbank Holdings, Inc.

LEXX and

Correlation & Price change

A.I.dvisor tells us that LEXX and PDSB have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that LEXX and PDSB's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LEXX
1D Price
Change %
LEXX100%
-3.17%
PDSB - LEXX
31%
Poorly correlated
-2.48%
ERAS - LEXX
28%
Poorly correlated
+1.75%
MIST - LEXX
28%
Poorly correlated
+0.64%
VERV - LEXX
28%
Poorly correlated
N/A
STRO - LEXX
27%
Poorly correlated
-3.04%
More